<DOC>
	<DOCNO>NCT01959022</DOCNO>
	<brief_summary>This study assess effect medication doxazosin sleep men woman PTSD . Sleep measure objectively home use portable sleep recorder wrist actigraphy .</brief_summary>
	<brief_title>A Pilot Study Assess Effects Doxazosin Polysomnography PTSD</brief_title>
	<detailed_description>This pilot study assess effect doxazosin objective measure sleep PTSD subject use home ambulatory polysomnography . Twenty ( 20 ) men woman chronic PTSD enrol San Francisco Veterans Affairs Medical Center . After initial screening , subject complete 1 week baseline assessment include 2 night home ambulatory polysomnography . They participate 2-week flexible-dose titration doxazosin base clinical response adverse effect follow 6 week steady dose treatment end 2 night home polysomnography . Subjective rater-based assessment conduct baseline set interval end treatment . Wrist actigraphy measurement also make baseline end treatment economical , fairly valid unobtrusive measure sleep duration . We hypothesize doxazosin associate increase total sleep time ( TST ) decrease wake time sleep onset ( WASO ) . We hypothesize doxazosin also associate clinical gain respect nightmare , subjective sleep quality , non-sleep PTSD symptom , depression symptom , quality life .</detailed_description>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Doxazosin</mesh_term>
	<criteria>1 . Age 1869 2 . Current full partial syndromal PTSD least 3 month duration index CAPS ( Clinicianadministered PTSD scale ) score &gt; 30 3 . CAPS recurrent distress dreams item &gt; /= 5 1. alcohol drug abuse/dependence last 3 month 2. lifetime history psychiatric disorder psychotic feature , bipolar disorder , obsessivecompulsive disorder 3. exposure trauma within last 3 month 4. prominent suicidal homicidal ideation 5. sleep apnea diagnosis positive screen sleep apnea Type III device . 6. neurologic disorder systemic illness affect CNS function 7. history brain trauma head injury loss consciousness great 10 minute 8. chronic unstable medical illness include unstable angina , myocardial infarction within past 6 month , congestive heart failure , preexist hypotension orthostatic hypotension , chronic renal hepatic failure , pancreatitis 9. pregnancy , breastfeed and/or refusal use effective birth control 10. previous serious adverse reaction alpha1antagonist ( priapism , hepatitis , angioedema , intraoperative floppy iris syndrome ) 11. current use trazodone , hypnotics/benzodiazepines , mirtazapine , atypical antipsychotic , betaadrenergic blocker , alpha2agonists , current prazosin alpha1antagonists 12. previous nonresponse prazosin treatment PTSD relate sleep disturbance Participants take SSRIs , bupropion , venlafaxine duloxetine may include stable dose 2 month . Participants may include stable psychotherapy treatment 2 month and/or begin new psychotherapy trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Posttramatic Stress Disorder</keyword>
	<keyword>Post-traumatic Stress Disorder</keyword>
	<keyword>PTSD</keyword>
	<keyword>Doxazosin</keyword>
	<keyword>Nightmares</keyword>
	<keyword>Sleep Disturbance</keyword>
</DOC>